Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1995
12/21/1995WO1995034554A1 Substituted arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria
12/21/1995WO1995034553A1 Thiopyridines for use in the control of helicobacter bacteria
12/21/1995WO1995034547A1 C-4 amide substituted compounds and their use as therapeutic agents
12/21/1995WO1995034546A1 Benzopyrans and their use as therapeutic agents
12/21/1995WO1995034545A1 Benzopyrans and their use as therapeutic agents
12/21/1995WO1995034544A1 Bioactive acetogenins and derivatives
12/21/1995WO1995034540A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
12/21/1995WO1995034539A1 4-carbamoyloxy-piperidine-1-carboxylic acid esters: inhibitors of cholesterol absorption
12/21/1995WO1995034535A1 Novel farnesyl transferase inhibitors, their preparation and pharmaceutical compositions containing same
12/21/1995WO1995034534A1 Enzyme inhibitors
12/21/1995WO1995034533A1 Water-soluble nimesulide salt, and uses thereof for the treatment of inflammations
12/21/1995WO1995034313A1 Methods for treating cancer and other cell proliferative diseases
12/21/1995WO1995034306A1 Use of immunosuppressive agents for the treatment of schizophrenia
12/21/1995WO1995034305A1 Use of r-(+)-n-propyl[(pyrrolidinyl-1)-1 propyl-2]-10 phenothiazinecarboxamide as an andidepressant
12/21/1995WO1995034304A1 Pharmacologically active 2-mercaptobenzimidazole derivatives
12/21/1995WO1995034303A1 Method for the treatment, prevention or minimization of hair loss
12/21/1995WO1995034302A2 Method for reducing intraocular pressure in the mammalian eye by administration of calcium chelators
12/21/1995WO1995034301A1 Energy substrates
12/21/1995WO1995034300A1 Process for the preparation of acanthoic acid and pharmaceutical composition comprising same
12/21/1995WO1995034299A1 Inhibition of intraoperative miosis/production of mydriasis by calcium channel blockers
12/21/1995WO1995034298A1 Inhibition of intraoperative miosis/production of mydriasis by local anesthetics
12/21/1995WO1995034296A1 Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory
12/21/1995WO1995034286A1 Transmucosal delivery system
12/21/1995WO1995034284A1 Pharmaceutical preparation with a hydrophobic active substance and an effervescent system, and process for preparing said preparation
12/21/1995WO1995034283A1 Effervescent system with an alkali- and/or metal-sensitive pharmaceutical active substance and process for producing the same
12/21/1995WO1995034282A1 Use of sophorolipids and cosmetic and dermatological compositions
12/21/1995WO1995034280A1 Methods of lightening hyperpigmented regions in mammalian skin
12/21/1995WO1995034262A1 Transdermal treatment of malaria
12/21/1995WO1995034201A1 pp60PIK: A DOWNSTREAM ELEMENT IN INSULIN SIGNALING
12/21/1995WO1995030423A3 Cancer treatment and metastasis prevention
12/21/1995WO1995024894A3 Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents
12/21/1995WO1995022965A3 Nasal and ocular administration of ketamine to manage pain and for detoxification
12/21/1995WO1995020660A3 Immunization by inoculation of dna transcription unit
12/21/1995WO1995018616A3 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/nmda receptor
12/21/1995DE4420708A1 Pharmaceutical compsn. for inhalation
12/21/1995CA2192984A1 Lactam inhibitors of cholesterol esterase
12/21/1995CA2192977A1 Bioactive acetogenins and derivatives
12/21/1995CA2192972A1 Rapamycin amidino carbamates and pharmaceutical compositions containing them
12/21/1995CA2192668A1 Amidino sulfone derivatives for use as inos inhibitors claims
12/21/1995CA2192595A1 Use of sophorolipids and cosmetic and dermatological compositions
12/21/1995CA2192486A1 Pp60pik: a downstream element in insulin signaling
12/21/1995CA2192460A1 Cyclobut-3-ene-1,2-dione derivatives as smooth muscle relaxants
12/21/1995CA2192459A1 4-carbamoyloxy-piperidine-1-carboxylic acid esters: inhibitors of cholesterol absorption
12/21/1995CA2192389A1 Novel farnesyl transferase inhibitors, their preparation and pharmaceutical compositions containing same
12/21/1995CA2192338A1 Aryl, alkyl, alkenyl, and alkynylmacrolides
12/21/1995CA2192206A1 Thiopyridines for use in the control of helicobacter bacteria
12/21/1995CA2192202A1 Substituted arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria
12/21/1995CA2192097A1 2-amino-3-aroyl-benzo¬.beta.|thiophenes and method of making the same
12/21/1995CA2190611A1 Covalently coupled benzoylecgonine, ecgonine and ecgonidine derivatives
12/21/1995CA2169747A1 Water-soluble nimesulide salt, and uses thereof for the treatment of inflammations
12/21/1995CA2152030A1 Heterocyclyloxybenzoylguanidines
12/21/1995CA2152005A1 L-carnitine salt and compositions containing same
12/21/1995CA2150407A1 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
12/20/1995EP0687676A1 Purification of a cephalosporin salt
12/20/1995EP0687675A2 Irreversible HIV protease inhibitors, intermediates, compositions and processes for the preparation thereof
12/20/1995EP0687673A1 Oxazole derivatives as antitumoral agents
12/20/1995EP0687473A1 Optical isomerization inhibitor
12/20/1995EP0687472A2 Potentiation of drug response by a serotonin 1A receptor antagonist
12/20/1995EP0687469A2 Anti-arrhythmic 3,7-diazabicyclo (3,3,1)nonane compounds
12/20/1995EP0687468A2 Pharmaceutical composition for suppressing infiltration of eosinophils
12/20/1995EP0687467A2 Cosmetic and dermatological combinations containing glycerylalkylethers as active ingredients
12/20/1995EP0687465A1 Use of glycyrrhizinic acid and its metabolite (glycyrrhetinic acid)as drug in the preparation of a medicament for the treatment of viral and allergic diseases
12/20/1995EP0687418A2 A lipid composition, its use for normalizing injury response
12/20/1995EP0687411A1 Hepatic graft preservative composition and a method for viable preservation of the hepatic graft
12/20/1995EP0687268A1 Spiroazacyclic derivatives as substance p antagonists
12/20/1995EP0687267A1 Pyrrolo-pyridine derivatives
12/20/1995EP0687266A1 Heterocyclic compounds and their preparation and use
12/20/1995EP0687265A1 Heterocyclic compounds and their preparation and use
12/20/1995EP0687264A1 Method for preparing n-methyl 2-(3-pyridyl) (1r,2r)-2-tetrahydrothiopyrancarbothioamide-1-oxide
12/20/1995EP0687260A1 Process for the preparation of 9-desoxotaxanes
12/20/1995EP0687259A1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same
12/20/1995EP0687256A1 Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions
12/20/1995EP0687255A1 Quinolone derivatives as dopamine d4 ligands
12/20/1995EP0687254A1 4-aminopyridines, their preparation and their use as antithrombotic agent
12/20/1995EP0687253A1 New 4-aminopyridines, process for preparing the same and medicaments containing the same
12/20/1995EP0687252A1 2-phenoxyethylamine derivatives, their preparation and their therapeutical use
12/20/1995EP0687251A1 1,3-dihydroindol-2-one derivatives substituted in position 3 by a nitrogen group as vasopressin and/or ocytocine agonists and/or antagonists
12/20/1995EP0687249A1 Balanoids
12/20/1995EP0687184A1 Recombinant adenoviruses and use thereof in gene therapy for treating eye diseases
12/20/1995EP0687179A1 Use of antiepileptics such as carbamazepine and oxcarbazepine for treating aids-related neural disorders
12/20/1995EP0687178A1 Use of 2h-1,2,4-benzothiadiazine 3(4h)-one 1,1 dioxide derivatives as non-competitive nmda receptor antagonists
12/20/1995EP0687177A1 Use of lamotrigine for treating aids-related neural disorders
12/20/1995EP0687176A1 Use of riluzole for treating aids-related neural disorders
12/20/1995EP0687175A1 Method for treating emotional or mental illness and emotional or mental illness concomitant with seizures
12/20/1995EP0687174A1 Crystalline cyclodextrin inclusion complexes of ranitidine hydrochloride and process for their preparation
12/20/1995EP0679082A4 C10 taxane derivatives and pharmaceutical compositions.
12/20/1995EP0668762A4 Butenyl-substituted taxanes and composition.
12/20/1995EP0667772A4 Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them.
12/20/1995EP0645997B1 Cosmetic containing phospholipids and fluorocarbon compounds
12/20/1995EP0605639B1 Air treatment plant for foodstuff comprising a trough with an adjustable width
12/20/1995EP0600004A4 Sustained-release martrices for dental application.
12/20/1995EP0596049A4 Defoaming composition
12/20/1995EP0553169B1 A method for drug formulation and a pharmaceutical composition
12/20/1995EP0541722B1 Compounds and methods for inhibiting gene expression
12/20/1995EP0533833B1 Phosphorous produgs
12/20/1995EP0506961B1 External preparation for skin
12/20/1995EP0462258B1 Ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds
12/20/1995EP0435902B1 2-hydroxy-3-phenoxy-propyl-substituted piperazines, their manufacture and use
12/20/1995EP0290496B2 Use of an adenosine, hypoxanthine and ribose-containing solution for improved protection of the heart during surgery
12/20/1995EP0180581B2 Drug preparations of reduced toxicity
1 ... 6958 6959 6960 6961 6962 6963 6964 6965 6966 6967 6968 6969 6970 6971 6972 6973 6974 6975 6976 6977 6978 ... 7860